CHICAGO, Nov. 17, 2021 /PRNewswire-PRWeb/ -- Ziegler, a specialty investment bank, is pleased to announce it served as the exclusive financial advisor to CareSignal (St. Louis, MO), the pioneer of Deviceless Remote Patient Monitoring technology, on its acquisition by Lightbeam Health Solutions (Irving, TX), a leading population health management solution.
With this transaction, Lightbeam is now able to integrate scalable, evidence-based remote engagement as well as monitoring capabilities into its core population health offering, which serves more than 42 million patient lives across the United States.
CareSignal brings over 30 condition-specific programs, proven real-world ROI, and a suite of robust AI-based predictive models that complement Lightbeam's sophisticated population health analytics platform. Combined with the real-time cohort generation capabilities at the core of Lightbeam, CareSignal programs covering chronic conditions, behavioral health, social determinants of health, maternal health, and additional use cases will rapidly generate scalable returns on investment for value-based providers, payers, and self-insured employers.
Together, Lightbeam and CareSignal will deliver best-in-class population-level stratification, actionable real-time insight delivery, and clinical outcomes improvements. Current and future industry partners of both companies will benefit from the validated offerings and deep focus on client success.
Mark Turco, Managing Director in Ziegler's Healthcare Corporate Finance practice, commented, "We were honored to work with the phenomenal team at CareSignal. The Company has developed a truly unique approach to Remote Patient Monitoring (RPM), and the partnership with Lightbeam provides a tremendous opportunity to further unlock the potential of RPM at population-level scale in value-based care settings. We are thrilled to have represented CareSignal in this transaction."
Blake Marggraff, CareSignal CEO and Co-Founder stated, "The Ziegler team was a great partner for our organization given their deep domain expertise and ability to articulate the nuanced CareSignal value proposition to the marketplace. We thank them for providing valuable strategic and financial advice throughout the sale process."
Ziegler's Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.
For more information about Ziegler, please visit us at http://www.ziegler.com.
Mark Turco is a Managing Director with Ziegler's Healthcare Corporate Finance Practice. Mr. Turco specializes in advising healthcare information technology and healthcare services companies on a spectrum of strategic and financing alternatives, including merger and acquisitions, capital raising transactions and partnership development.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm. Specializing in the healthcare, senior living and education sectors, as well as general municipal and structured finance, enables Ziegler to generate a positive impact on the clients and communities it serves. Headquartered in Chicago with regional and branch offices throughout the United States, Ziegler provides its clients with capital raising, strategic advisory services, equity and fixed income sales & trading and research. To learn more, visit http://www.ziegler.com.
Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client's experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.
Christine McCarty, Ziegler, 3125961617, [email protected]